Dexcom G5 CGM System is now covered under Medicare

People covered by Medicare who have either Type 1 or Type 2 diabetes and intensively manage their insulin will now be able to obtain reimbursement. **

** The beneficiary may NOT use their phone or smart device for display of Continuous Glucose Monitoring (CGM) data and still be eligible for reimbursement by Medicare for Therapeutic CGM. The beneficiary must meet the qualifying criteria on an ongoing basis, as outlined by CMS, to be eligible for reimbursement.

Economics & Reimbursement

Become a Dexcom Warrior

The Dexcom community is full of Warriors who not only take control of their diabetes through proper glucose management, they also live life to the fullest—without limitations. Read their stories and share yours.

* If your glucose alerts and readings from the G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.

** The beneficiary may NOT use their phone or smart device for display of Continuous Glucose Monitoring (CGM) data and still be eligible for reimbursement by Medicare for Therapeutic CGM.

† Separate Follow App required.

BRIEF SAFETY STATEMENT

Failure to use the Dexcom G6 Continuous Glucose Monitoring System (G6) and its components according to the instructions for use provided with your device and available at https://www.dexcom.com/safety-information and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the G6 do not match symptoms or expectations or you’re taking over the recommended maximum dosage amount of 1000mg of acetaminophen every 6 hours, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency.